To summarise, we have identified an IDO1 induced tryptophan metabolic pathway regulated by IFNγ producing immune cells driving IBD-CRC, highlighting the intricate role of the immune and interferon gamma response in IBD-CRC (Fig. 7E). Here, IFNG is linked to inflammatory bowel disease.